Considering that most AMMD patients are middle-aged at the time of diagnosis, their clinical progression rate over their lifetime may be quite significant ( 33 ).
← all excerpts
Clinical and radiological course of asymptomatic and hemodynamically stable moyamoya disease: a systematic review and meta-analysis.
1
—
—